Successfully streamlined the Fluorescence In Situ Hybridization (FISH) workflow for challenging solid tumor samples, decreasing average analysis time by 15% while consistently maintaining a >99% accuracy rate. This involved optimizing probe hybridization protocols and enhancing image capture techniques, particularly crucial for specimens with low cellularity and complex chromosomal rearrangements often encountered in oncology diagnostics.
During my tenure as Senior Cytogenetic Technologist at Penn Medicine, I routinely managed over 500 complex prenatal cases annually, encompassing cell culture of amniocytes and chorionic villi, high-resolution karyotyping, and identifying subtle chromosomal aberrations utilizing MetaSystems Metafer image analysis. I also executed over 800 FISH assays yearly on diverse sample types, including bone marrow, applying multi-probe panels and fluorescence microscopy to detect critical gene rearrangements and copy number variations for patient stratification. Furthermore, I initiated a quality improvement project to refine DNA extraction protocols for archival samples, which improved DNA yield consistency by 20%.
Clarity Genomics Solutions' commitment to advancing next-generation cytogenetic diagnostics, especially in rare inherited disorders and oncology, deeply resonates with my professional goals. Your recent initiatives in automating complex aberration detection and expanding comprehensive genomic panels align perfectly with my deep experience in intricate prenatal diagnostics and robust cell culture techniques. My analytical precision, honed through years of identifying subtle chromosomal abnormalities using advanced imaging platforms like ASI GenASIs, would directly contribute to your diagnostic accuracy and innovative assay development.
My extensive experience as a Senior Cytogenetic Technologist, particularly in complex case analysis, workflow optimization, and utilizing cutting-edge image analysis software, strongly positions me to contribute to Clarity Genomics Solutions’ reputation for diagnostic excellence. I am confident that my skills in karyotyping, FISH, and diverse cell culture methodologies would be an immediate asset. I welcome the opportunity to discuss how my expertise can support your team’s vital work in a more detailed conversation.
Best regards,
Jessica Thompson